Clinical Laserthermia Systems AB OMXSTO:CLS_B:
CLS ENTERS RESEARCH AGREEMENT WITH THE U.S. NATIONAL CANCER INSTITUTE
AGREEMENT EXTENDS CLS NON-SPONSORED COLLABORATION THROUGH 2029
CLS Enters Research Agreement With U.S. National Cancer Institute
Earlier from Clinical Laserthermia Systems Ab Class B
- Sweden's CLS Q1 sales fall 72% after partner talks
- CLS Receives Order Worth SEK 23 Mln For Prism Business
- Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
- CLS Initiates Recruitment Process For Permanent Chief Financial Officer